Susquehanna International Group, LLP Eagle Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$4.26 - $6.51 $159,788 - $244,183	-37,509 Reduced 77.19%	11,087 $58,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $27,113 - $89,069	5,856 Added 13.7%	48,596 $254,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $216,985 - $326,406	-14,266 Reduced 25.03%	42,740 $674,000
Q2 2023 Aug 11, 2023	SELL	$17.74 - $31.87 $290,829 - $522,476	-16,394 Reduced 22.34%	57,006 $1.11 Million
Q1 2023 May 16, 2023	BUY	$25.06 - $34.09 $1.36 Million - $1.86 Million	54,449 Added 287.31%	73,400 $2.08 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $1,174 - $1,869	47 Added 0.25%	18,951 $553,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $499,443 - $890,756	18,904 New	18,904 $499,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $389,948 - $485,308	-9,451 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $352,850 - $416,329	-7,915 Reduced 45.58%	9,451 $468,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $348,094 - $432,269	7,597 Added 77.77%	17,366 $884,000
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $18,129 - $23,092	414 Added 4.43%	9,769 $545,000
Q2 2021 Aug 11, 2021	BUY	$36.86 - $44.5 $125,250 - $151,211	3,398 Added 57.04%	9,355 $400,000
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $240,186 - $303,628	5,957 New	5,957 $249,000
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $265,839 - $327,138	-6,372 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $24,914 - $34,511	-673 Reduced 9.55%	6,372 $271,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $78,088 - $136,479	-2,272 Reduced 24.39%	7,045 $324,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $350,704 - $395,028	-6,586 Reduced 41.41%	9,317 $527,000
Q2 2019 Aug 16, 2019	BUY	$46.61 - $58.45 $224,333 - $281,319	4,813 Added 43.4%	15,903 $885,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $52,063 - $65,288	1,117 Added 11.2%	11,090 $617,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $451,316 - $604,946	-11,674 Reduced 53.93%	9,973 $504,000
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $654,056 - $1.21 Million	17,812 Added 464.46%	21,647 $872,000
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $915,042 - $1.17 Million	-17,543 Reduced 82.06%	3,835 $202,000
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $1.06 Million - $1.3 Million	21,378	21,378 $1.14 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account